LUX-Lung 8: A Global Phase III Trial of Afatinib (A) vs Erlotinib (E) as Second-Line Treatment in Patients (Pts) With Advanced Squamous Cell Carcinoma (SCC) of the Lung Following First-Line Platinum-Based Chemotherapy
Articles > Article · 2015
Authors: Vera Hirsh, Shirish Gadgeel, Jean-Charles Soria, Enriqueta Felip, Manuel Cobo, Shun Lu, Konstantinos Syrigos, Ki Hyeong Lee, Erdem GÖKER, Vassilis Georgoulias, Wei Li, Dolores Isla, Salih Zeki Guclu, Alessandro Morabito, Young Joo Min, Andrea Ardizzoni, Jamie Cromer, Bushi Wang, Vikram Chand, Glenwood Goss
Chest, International, WoS, 2015, vol 148, pp 585A-585A